Intercure Ltd (INCR) Return on Equity ROE from the fourth quarter 2025 to fourth quarter 2024 and annually, average high and low, overall ranking from Dec 31 2025 to Dec 31 2024 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Intercure Ltd   (NASDAQ: INCR)

Intercure Ltd 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Intercure Ltd in the fourth quarter 2025?
Intercure Ltd recorded a cumulative net loss of $-37 million during 12 months ending in the fourth quarter 2025, resulting in a negative return on equity (ROE) of -9.28%.

Within the Major Pharmaceutical Preparations industry 91 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the third quarter 2025 from 0 to 2989.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Dec 31 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2024)
IV. Quarter
Y / Y Equity Change 264.11 % 264.11 % 264.11 % 264.11 % -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions -37 -20 -20 -20 -20
Return On Equity (TTM) -9.28 % -6.07 % -7.79 % -10.89 % -18.08 %
INCR's Total Ranking # 2989 # 0 # # #
Equity (TTM) in Millions 396 396 396 396 109
Seq. Equity Change 0 % 0 % 0 % 264.11 % -0 %
Seq. Net Income Change - - - - -

Back to INCR Management Effectiveness >> INCR's 5 Years Annual ROE >> Compare INCR ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 92
Sector # 262
Overall # 2989

Return On Equity Statistics
High Average Low
8.39 %
-6.3 %
-18.3 %
(Dec 31 2022)   (Dec 31 2024)



  News about Intercure Ltd Return on Equity ROE

InterCure Overcomes Challenges, Provides Update on Nir Oz Facility Amidst Security Situation in Israel


InterCure Provides an Update Regarding Nir Oz Facility
InterCure, the leading medical cannabis company in Israel and outside of North America, has released an update regarding the status of its facility in Kibbutz Nir Oz, also known as the Southern Israel Site. This update comes in response to the security situation in Israel and its impact on the company and its employees.
In October 2023, InterCure provided an initial update on the security situation. Now, the company provides further information on the status of its facility. Despite the challenges posed by the security situation, InterCure remains committed to ensuring the safety of its employees and the successful operation of its operations.



INCR Annual Return On Equity (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Equity in Millions 396 109 126 148 151
Y / Y Equity Change 264.11 % -13.68 % -14.89 % -2.01 % -
Net Income in Millions -37 -20 -17 13 2
Y / Y Net Income Change - - - 477.71 % -
Return On Equity -9.28 % -18.08 % -13.69 % 8.81 % 1.49 %

Back to INCR Management Effectiveness >> INCR's 5 Years Annual ROE >> Compare INCR ROE to its Competitors




More Return On Equity Ratios
Major Pharmaceutical Preparations Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
INCR's' Return on Equity at Yahoo Finance
INCR's Roe Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for INCR's Competitors
Subscribers only: Roe for Intercure Ltd 's Suppliers
Subscribers only: Return On Equity for INCR's Customers




Companies with similar Return On Equity at Dec 31 2025, within Healthcare Sector ROE

Date modified: 2026-07-07T11:48:09+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.